ArticleAesthetic plastic surgery2026
Oncoplastic Breast Surgery: Optimizing Resection Margins in Addition to Aesthetic Outcomes.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Assessing Recent Trends in Lumpectomy and Concomitant Oncoplastic Procedures: A National Insurance Database Analysis.Annals of surgical oncology · 2026Article
- Essentials for optimizing outcomes in oncoplastic breast reconstruction.Gland surgery · 2026Review
- Surgical Burden of Breast Cancer Treatment: Implications of Mastectomy, Breast Conservation, and Reconstruction Choices.Medicina (Kaunas, Lithuania) · 2026Review
- Personalized Breast Reconstruction After Breast-Conserving Therapy: Risk-Informed Approaches to Technique Selection and Timing.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to determine whether oncoplastic surgery improves resection margins compared to lumpectomy alone in patients undergoing breast conserving therapy, as determined by re-excision rates.
backgroundPrior studies have demonstrated that oncoplastic breast surgery results in better aesthetic outcomes than lumpectomy alone in select patient cohorts. However, there is a dearth of literature on whether oncoplastic breast surgery also provides oncologic benefit.
methodsThis is a retrospective cohort investigation of women who underwent breast conserving therapy at our institution between 2010 and 2023. Breast cancer patients who received either lumpectomy alone or oncoplastic breast surgery during this period were included. The rate of re-excision of margins within the 6-month period following the index procedure was compared between patients who underwent lumpectomy along and those who underwent oncoplastic breast surgery.
resultsOf 4,673 study patients, 4,164 (89.6%) underwent lumpectomy alone and 488 (10.4%) underwent oncoplastic breast surgery. Oncoplastic surgery became significantly more prevalent over the course of the study period (p = 0.04). The re-excision rate was higher in the lumpectomy cohort that in the oncoplastic surgery cohort (17% vs. 13%). After adjusting for potential confounders using propensity score matching, oncoplastic surgery was associated with significantly lower odds of re-excision (OR 0.7, 95% confidence interval 0.4-1.0, p = 0.05).
conclusionsOncoplastic surgery may help to better achieve clear surgical margins compared to lumpectomy alone, and an increasing number of patients are receiving oncoplastic breast surgery. This suggests that, whenever possible, efforts should be made to offer oncoplastic surgery to appropriately selected patients. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41258921What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.